Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5091)
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
7,500
Price
$26.34
Total Value
$197.55K
Shares Held After
24,808
% of Holdings
23.2%
NEUROCRINE BIOSCIENCES INC (NBIX)
Delaet Ingrid — Chief Regulatory Officer
Shares
2,261
Price
$156.71
Total Value
$354.32K
Shares Held After
16,225
% of Holdings
12.2%
HEALTHEQUITY, INC. (HQY)
Fiore Michael Henry — EVP, CHIEF COMMERCIAL OFFICER
Shares
3,142
Price
$95.00
Total Value
$298.49K
Shares Held After
59,113
% of Holdings
5.0%
ZIMMER BIOMET HOLDINGS, INC. (ZBH)
Yi Sang — Group President, Asia Pacific
Shares
800
Price
$82.66
Total Value
$66.13K
Shares Held After
27,251
% of Holdings
2.9%
ZIMMER BIOMET HOLDINGS, INC. (ZBH)
Yi Sang — Group President, Asia Pacific
Shares
4,200
Price
$82.64
Total Value
$347.09K
Shares Held After
28,051
% of Holdings
13.0%
AN2 Therapeutics, Inc. (ANTX)
Williams Sarah Joanne — Principal Accounting Officer
Shares
265
Price
$4.43
Total Value
$1.17K
Shares Held After
66,583
% of Holdings
0.4%
Inogen Inc (INGN)
Yi Boyer Jennifer M — EVP Entrprs Enblmnt, Ch HR Off
Shares
10,770
Price
$6.53
Total Value
$70.31K
Shares Held After
15,977
% of Holdings
40.3%
Connect Biopharma Holdings Ltd (CNTB)
Huang James — Director
Shares
150,000
Price
$2.48
Total Value
$371.61K
Shares Held After
13,310,000
% of Holdings
1.1%
Korro Bio, Inc. (KRRO)
Aiyar Ram — Director
Shares
15,152
Price
$12.98
Total Value
$196.67K
Shares Held After
74,848
% of Holdings
16.8%
AUNA S.A. (AUNA)
Zamora Leon Jesus — Director
Shares
6,420
Price
$4.15
Total Value
$26.64K
Shares Held After
69,130
% of Holdings
9.3%
Protagonist Therapeutics, Inc (PTGX)
Waddill William D. — Director
Shares
9,000
Price
$99.64
Total Value
$896.76K
Shares Held After
7,825
% of Holdings
53.5%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
1,961
Price
$165.30
Total Value
$324.15K
Shares Held After
3,065,452
% of Holdings
0.1%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
92,877
Price
$164.56
Total Value
$15.28M
Shares Held After
3,067,413
% of Holdings
2.9%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
6,198
Price
$163.97
Total Value
$1.02M
Shares Held After
3,160,290
% of Holdings
0.2%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
63,020
Price
$162.86
Total Value
$10.26M
Shares Held After
3,166,488
% of Holdings
2.0%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
6,888
Price
$164.75
Total Value
$1.13M
Shares Held After
3,229,508
% of Holdings
0.2%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
19,832
Price
$163.57
Total Value
$3.24M
Shares Held After
3,236,396
% of Holdings
0.6%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
2,225
Price
$162.44
Total Value
$361.43K
Shares Held After
3,256,228
% of Holdings
0.1%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
5,256
Price
$161.64
Total Value
$849.58K
Shares Held After
3,258,453
% of Holdings
0.2%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
4,579
Price
$160.50
Total Value
$734.93K
Shares Held After
3,263,709
% of Holdings
0.1%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
11,760
Price
$159.57
Total Value
$1.88M
Shares Held After
3,268,288
% of Holdings
0.4%
SI-BONE, Inc. (SIBN)
Davis Timothy E JR — Director
Shares
3,500
Price
$14.14
Total Value
$49.49K
Shares Held After
65,722
% of Holdings
5.1%
Ascendis Pharma A/S (ASND)
SMITH SCOTT THOMAS — EVP & Chief Financial Officer
Shares
250
Price
$223.32
Total Value
$55.83K
Shares Held After
4,267
% of Holdings
5.9%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
100
Price
$223.50
Total Value
$22.35K
Shares Held After
900
% of Holdings
11.1%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$222.30
Total Value
$44.46K
Shares Held After
800
% of Holdings
25.0%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$223.76
Total Value
$44.75K
Shares Held After
600
% of Holdings
33.3%
CRISPR Therapeutics AG (CRSP)
Patel Naimish — Chief Medical Officer
Shares
3,786
Price
$55.62
Total Value
$210.58K
Shares Held After
19,357
% of Holdings
16.4%
WORK Medical Technology Group LTD (WOK)
HRT FINANCIAL LP — 10% Owner
Shares
2,619,607
Price
$0.10
Total Value
$261.96K
Shares Held After
0
% of Holdings
100.0%
ILLUMINA, INC. (ILMN)
Ericksen Scott D — VP, Chief Accounting Officer
Shares
500
Price
$160.00
Total Value
$80.00K
Shares Held After
14,446
% of Holdings
3.3%
Processa Pharmaceuticals, Inc. (PCSA)
Ng George K — Director
Shares
2,129
Price
$2.57
Total Value
$5.47K
Shares Held After
9,970
% of Holdings
21.4%
Processa Pharmaceuticals, Inc. (PCSA)
Young David — Director
Shares
1,786
Price
$2.57
Total Value
$4.59K
Shares Held After
17,131
% of Holdings
10.4%
Processa Pharmaceuticals, Inc. (PCSA)
Guy Wendy — Chief Administrative Officer
Shares
1,829
Price
$2.57
Total Value
$4.70K
Shares Held After
9,840
% of Holdings
18.6%
Processa Pharmaceuticals, Inc. (PCSA)
Lin Patrick — Chief Business - Strategy Off
Shares
1,582
Price
$2.57
Total Value
$4.07K
Shares Held After
9,176
% of Holdings
17.2%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
2,292
Price
$2.57
Total Value
$5.89K
Shares Held After
10,758
% of Holdings
21.3%
ILLUMINA, INC. (ILMN)
Davies Scott M — Chief Legal Officer
Shares
615
Price
$160.00
Total Value
$98.40K
Shares Held After
21,568
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$559.41
Total Value
$179.01K
Shares Held After
40,513
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
841
Price
$558.81
Total Value
$469.96K
Shares Held After
40,833
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
918
Price
$557.80
Total Value
$512.06K
Shares Held After
41,674
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
461
Price
$556.67
Total Value
$256.62K
Shares Held After
42,592
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,000
Price
$555.59
Total Value
$555.59K
Shares Held After
43,053
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
817
Price
$554.57
Total Value
$453.08K
Shares Held After
44,053
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
823
Price
$553.73
Total Value
$455.72K
Shares Held After
44,870
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
680
Price
$552.58
Total Value
$375.75K
Shares Held After
45,693
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
986
Price
$551.34
Total Value
$543.62K
Shares Held After
46,373
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,605
Price
$550.60
Total Value
$883.71K
Shares Held After
47,359
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
769
Price
$549.59
Total Value
$422.64K
Shares Held After
48,964
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$548.60
Total Value
$153.61K
Shares Held After
49,733
% of Holdings
0.6%
Monte Rosa Therapeutics, Inc. (GLUE)
Townson Sharon — Chief Scientific Officer
Shares
6,000
Price
$19.87
Total Value
$119.22K
Shares Held After
67,845
% of Holdings
8.1%
MediWound Ltd. (MDWD)
Rubinstein Samuel — Director
Shares
150
Price
$14.33
Total Value
$2.15K
Shares Held After
2,993
% of Holdings
5.0%
Personalis, Inc. (PSNL)
Hall Christopher M — Director
Shares
80,091
Price
$11.02
Total Value
$882.60K
Shares Held After
235,986
% of Holdings
25.3%
Showing 551–600 of 5091 transactions (page 12 of 102)